|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,570.00 JPY | -1.51% |
|
+5.66% | -24.21% |
| 02-19 | Japan Panel Clears First iPS Cell Therapies for Conditional Sale | MT |
| 02-19 | Japanese government panel endorses Sumitomo Pharma's iPS-derived treatment for Parkinson's | RE |
| Market Cap | 38.31B 237M 207M 191M 177M 336M 22.46B 341M 2.29B 890M 11.09B 889M 869M | P/E 2025 |
-103x | P/E 2026 | -56.3x |
|---|---|---|---|---|---|
| Enterprise Value | 34.42B 213M 186M 171M 159M 302M 20.18B 307M 2.06B 799M 9.96B 798M 781M | EV / Sales 2025 |
356x | EV / Sales 2026 | 255x |
| Free-Float |
73.74% | Yield 2025 * |
-
| Yield 2026 | - |
| 1 day | -1.51% | ||
| 1 week | +5.66% | ||
| Current month | +5.66% | ||
| 1 month | +11.60% | ||
| 3 months | -35.18% | ||
| 6 months | -31.38% | ||
| Current year | -24.21% |
| 1 week | 4,090 |  | 4,965 |
| 1 month | 3,610 | | 4,965 |
| Current year | 3,610 | | 12,400 |
| 1 year | 3,610 | | 12,400 |
| 3 years | 1,443 | | 12,400 |
| 5 years | 1,287 | | 12,400 |
| 10 years | 1,287 | | 12,400 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 67 | 2020-05-31 | |
Yoshiki Sawa
CTO | Chief Tech/Sci/R&D Officer | 71 | 2021-07-31 |
| Investor Relations Contact | 44 | 2024-03-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 2020-07-31 | |
Yoshiki Sawa
BRD | Director/Board Member | 71 | 2021-07-31 |
Tadashi Samejima
BRD | Director/Board Member | 66 | 2022-05-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 25-02-17 | Others | Chief Technology Officer | 24,000 | 0.2989% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.51% | +5.66% | -19.82% | +101.06% | 237M | |
| +4.07% | +8.45% | +25.67% | -2.34% | 68.8B | |
| -0.24% | -3.13% | +49.38% | +223.97% | 55.21B | |
| +1.21% | +42.20% | +42.20% | +42.20% | 43.46B | |
| +0.31% | +8.44% | -49.83% | -53.39% | 41.18B | |
| -2.48% | +13.91% | +166.79% | -32.89% | 31.65B | |
| -1.32% | -4.79% | +58.07% | -25.22% | 30.37B | |
| +2.10% | +4.14% | +75.49% | +90.19% | 23.58B | |
| -0.34% | +8.92% | +5.03% | +186.61% | 19.33B | |
| -0.04% | +3.85% | +67.76% | +135.89% | 17.16B | |
| Average | +0.16% | +4.59% | +42.07% | +66.61% | 33.1B | |
| Weighted average by Cap. | +0.76% | +4.19% | +43.36% | +54.75% |
| 2025 | 2026 | |
|---|---|---|
| Net sales | 175M 1.08M 946K 872K 808K 1.53M 103M 1.56M 10.45M 4.07M 50.63M 4.06M 3.97M | 212M 1.31M 1.15M 1.06M 979K 1.86M 124M 1.89M 12.66M 4.92M 61.34M 4.92M 4.81M |
| Net income | -644M -3.98M -3.48M -3.21M -2.97M -5.64M -378M -5.74M -38.47M -14.96M -186M -14.93M -14.61M | -1.02B -6.31M -5.52M -5.09M -4.72M -8.96M -599M -9.1M -61.05M -23.74M -296M -23.7M -23.19M |
| Net Debt | -4.79B -29.61M -25.91M -23.88M -22.13M -42.01M -2.81B -42.69M -286M -111M -1.39B -111M -109M | -3.9B -24.08M -21.08M -19.42M -18M -34.17M -2.29B -34.73M -233M -90.57M -1.13B -90.42M -88.46M |
Employees
51
Sector
Pharmaceuticals
Calendar
08-12 -
Earnings release - Q1 2027
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-08 | JP¥4,570.00 | -1.51% | 94,600 |
| 26-07-07 | JP¥4,640.00 | -4.13% | 136,600 |
| 26-07-06 | JP¥4,840.00 | +3.97% | 216,800 |
| 26-07-03 | JP¥4,655.00 | +6.16% | 155,900 |
| 26-07-02 | JP¥4,385.00 | +2.57% | 127,200 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- 4894 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
